AVENUE THERAPEUTICS, INC.
Related Filers (27)
- Herskowitz Neil (19)
- Vazzano Joseph Walter (11)
- Fortress Biotech, Inc. (9)
- Lu Lucy (7)
- ROSENWALD LINDSAY A MD (7)
- InvaGen Pharmaceuticals, Inc. (6)
- KRANZLER JAY D (6)
- Davidow Robert L (4)
- Paley Jeffrey (3)
- Opaleye Management Inc. (3)
- Oltmans Curtis Gale (3)
- Reines Scott (2)
- SAMAD AKHTAR (2)
- WEISS MICHAEL S (2)
- Ingram Elizabeth Garrett (2)
- VANGUARD GROUP INC (2)
- VANGUARD INDEX FUNDS (2)
- Nantahala Capital Management, LLC (2)
- SABBY MANAGEMENT, LLC (2)
- CVI Investments, Inc. (2)
- MacLean Alexandra (2)
- Jin David (2)
- Charles Faith L. (2)
- Saxena Nishant (1)
- Gogtay Jaideep Ashok (1)
- Moore Thomas Gregory (1)
- INTRACOASTAL CAPITAL, LLC (1)
- Show More ...
Financials (27)
10-Q
Monday, 11/13/2023
Quarterly Report for period ending 2023-09-30
10-Q
Friday, 8/11/2023
Quarterly Report for period ending 2023-06-30
10-Q
Friday, 5/12/2023
Quarterly Report for period ending 2023-03-31
10-K
Friday, 3/31/2023
Annual Report for period ending 2022-12-31
10-Q
Thursday, 11/10/2022
Quarterly Report for period ending 2022-09-30
10-Q
Monday, 8/15/2022
Quarterly Report for period ending 2022-06-30
10-Q
Monday, 5/16/2022
Quarterly Report for period ending 2022-03-31
10-K
Friday, 3/25/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/15/2021
Quarterly Report for period ending 2021-09-30
10-Q
Monday, 8/16/2021
Quarterly Report for period ending 2021-06-30
10-Q
Monday, 5/17/2021
Quarterly Report for period ending 2021-03-31
10-K
Wednesday, 3/31/2021
Annual Report for period ending 2020-12-31
10-Q
Wednesday, 11/4/2020
Quarterly Report for period ending 2020-09-30
10-Q
Friday, 8/14/2020
Quarterly Report for period ending 2020-06-30
10-Q
Monday, 5/11/2020
Quarterly Report for period ending 2020-03-31
10-K
Monday, 3/30/2020
Annual Report for period ending 2019-12-31
10-Q
Wednesday, 11/13/2019
Quarterly Report for period ending 2019-09-30
10-Q
Wednesday, 8/14/2019
Quarterly Report for period ending 2019-06-30
10-Q
Monday, 5/13/2019
Quarterly Report for period ending 2019-03-31
10-K
Tuesday, 3/12/2019
Annual Report for period ending 2018-12-31
10-Q
Wednesday, 11/14/2018
Quarterly Report for period ending 2018-09-30
10-Q
Tuesday, 8/14/2018
Quarterly Report for period ending 2018-06-30
10-Q
Thursday, 5/3/2018
Quarterly Report for period ending 2018-03-31
10-K
Thursday, 3/1/2018
Annual Report for period ending 2017-12-31
10-Q
Thursday, 11/9/2017
Quarterly Report for period ending 2017-09-30
10-Q
Friday, 8/11/2017
Quarterly Report for period ending 2017-06-30
10-Q
Friday, 5/12/2017
Quarterly Report for period ending 2017-03-31
News (97)
8-K
Friday, 1/12/2024
Current report filing
8-K
Monday, 1/8/2024
Current report filing
8-K
Friday, 11/24/2023
Current report filing
8-K
Monday, 11/13/2023
Current report filing
8-K
Thursday, 11/2/2023
Current report filing
8-K
Thursday, 9/28/2023
Current report filing
8-K
Wednesday, 9/27/2023
Current report filing
8-K
Friday, 9/8/2023
Current report filing
8-K
Thursday, 8/10/2023
Current report filing
8-K
Friday, 7/21/2023
Current report filing
8-K
Wednesday, 7/5/2023
Current report filing
8-K
Monday, 6/26/2023
Current report filing
8-K
Monday, 5/22/2023
Current report filing
8-K
Friday, 5/12/2023
Current report filing
8-K
Monday, 4/17/2023
Current report filing
8-K
Thursday, 3/30/2023
Current report filing
8-K
Wednesday, 3/8/2023
Current report filing
8-K
Thursday, 3/2/2023
Current report filing
8-K
Friday, 2/10/2023
Current report filing
8-K
Friday, 2/3/2023
Current report filing
8-K
Wednesday, 2/1/2023
Current report filing
8-K
Wednesday, 1/25/2023
Current report filing
8-K
Thursday, 11/10/2022
Current report filing
8-K
Tuesday, 11/8/2022
Current report filing
8-K
Friday, 11/4/2022
Current report filing
8-K
Tuesday, 10/18/2022
Current report filing
8-K
Wednesday, 10/12/2022
Current report filing
8-K
Friday, 9/30/2022
Current report filing
8-K
Thursday, 9/22/2022
Current report filing
8-K
Wednesday, 8/31/2022
Current report filing
8-K
Friday, 8/12/2022
Current report filing
8-K
Wednesday, 8/3/2022
Current report filing
8-K
Friday, 7/29/2022
Current report filing
8-K
Wednesday, 5/25/2022
Current report filing
8-K
Monday, 5/16/2022
Current report filing
8-K
Friday, 5/13/2022
Current report filing
8-K
Tuesday, 4/5/2022
Current report filing
8-K
Wednesday, 3/30/2022
Current report filing
8-K
Monday, 3/21/2022
Current report filing
8-K
Tuesday, 3/8/2022
Current report filing
8-K
Wednesday, 2/16/2022
Current report filing
8-K
Friday, 2/11/2022
Current report filing
8-K
Friday, 1/7/2022
Current report filing
8-K
Thursday, 12/16/2021
Current report filing
8-K
Monday, 12/13/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Thursday, 11/4/2021
Current report filing
8-K
Monday, 10/25/2021
Current report filing
8-K
Tuesday, 9/21/2021
Current report filing
8-K
Friday, 9/3/2021
Current report filing
8-K
Wednesday, 9/1/2021
Current report filing
8-K
Friday, 8/27/2021
Current report filing
8-K
Thursday, 7/29/2021
Current report filing
8-K
Thursday, 7/15/2021
Current report filing
8-K
Monday, 6/14/2021
Current report filing
8-K
Monday, 5/3/2021
Current report filing
8-K
Monday, 4/5/2021
Current report filing
8-K
Monday, 3/1/2021
Current report filing
8-K
Tuesday, 2/16/2021
Current report filing
8-K
Friday, 1/8/2021
Current report filing
8-K
Thursday, 12/17/2020
Current report filing
8-K
Friday, 12/4/2020
Current report filing
8-K
Tuesday, 10/13/2020
Current report filing
8-K
Friday, 8/14/2020
Current report filing
8-K
Tuesday, 6/16/2020
Current report filing
8-K
Monday, 5/11/2020
Current report filing
8-K
Thursday, 4/23/2020
Current report filing
8-K
Monday, 3/30/2020
Current report filing
8-K
Thursday, 2/13/2020
Current report filing
8-K
Wednesday, 12/11/2019
Current report filing
8-K
Monday, 11/4/2019
Current report filing
8-K
Wednesday, 8/14/2019
Current report filing
8-K
Thursday, 8/1/2019
Current report filing
8-K
Wednesday, 6/19/2019
Current report filing
8-K
Monday, 6/3/2019
Current report filing
8-K
Monday, 5/13/2019
Current report filing
8-K
Tuesday, 4/30/2019
Current report filing
8-K
Thursday, 4/11/2019
Current report filing
8-K
Tuesday, 3/12/2019
Current report filing
8-K
Monday, 2/11/2019
Current report filing
8-K
Wednesday, 11/14/2018
Current report filing
8-K
Wednesday, 11/14/2018
Current report filing
8-K
Tuesday, 8/14/2018
Current report filing
8-K
Thursday, 6/14/2018
Current report filing
8-K
Friday, 5/25/2018
Current report filing
8-K
Monday, 5/21/2018
Current report filing
8-K
Thursday, 5/3/2018
Current report filing
8-K
Wednesday, 3/28/2018
Current report filing
8-K
Thursday, 3/1/2018
Current report filing
8-K
Tuesday, 1/2/2018
Current report filing
8-K
Thursday, 11/9/2017
Current report filing
8-K
Wednesday, 9/27/2017
Current report filing
8-K
Tuesday, 8/15/2017
Current report filing
8-K
Friday, 8/11/2017
Current report filing
8-K
Friday, 7/14/2017
Current report filing
8-K
Tuesday, 6/27/2017
Current report filing
8-K
Friday, 6/2/2017
Current report filing
Other (46)
EFFECT
Thursday, 2/1/2024
Notice of Effectiveness
EFFECT
Tuesday, 10/31/2023
Notice of Effectiveness
CORRESP
Monday, 10/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Monday, 10/30/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/27/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/24/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Tuesday, 6/27/2023
Notice of Effectiveness
CORRESP
Friday, 6/23/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Wednesday, 5/3/2023
Notice of Effectiveness
CORRESP
Monday, 5/1/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Tuesday, 2/14/2023
Exempt (Private) Offering
EFFECT
Thursday, 10/6/2022
Notice of Effectiveness
CORRESP
Wednesday, 10/5/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 10/5/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 12/10/2021
Notice of Effectiveness
CORRESP
Thursday, 12/9/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 10/1/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Friday, 10/1/2021
Notice of Effectiveness
EFFECT
Friday, 5/4/2018
Notice of Effectiveness
CORRESP
Thursday, 5/3/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 5/2/2018
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CERTNAS
Monday, 6/26/2017
None
EFFECT
Monday, 6/26/2017
Notice of Effectiveness
CORRESP
Friday, 6/23/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 6/23/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 6/21/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Wednesday, 6/21/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
8-A12B
Wednesday, 6/14/2017
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Tuesday, 6/13/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 6/13/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 4/28/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CT ORDER
Wednesday, 4/5/2017
Order Granting Confidential Treatment
10-12G/A
Monday, 3/27/2017
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Monday, 3/27/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G/A
Monday, 3/13/2017
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Monday, 3/13/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G/A
Monday, 3/6/2017
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Monday, 3/6/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Thursday, 1/12/2017
Exempt (Private) Offering
10-12G
Thursday, 1/12/2017
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Thursday, 1/12/2017
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G/A
Thursday, 2/18/2016
Initial general form for registration of a class of securities pursuant to Section 12(g)
CORRESP
Tuesday, 2/9/2016
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
10-12G
Wednesday, 12/30/2015
Initial general form for registration of a class of securities pursuant to Section 12(g)
Ownership (106)
4
Wednesday, 1/3/2024
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 1/2/2024
SABBY MANAGEMENT, LLC: Major Shareholders
SC 13G/A
Wednesday, 12/13/2023
Davidow Robert L: Major Shareholders
4
Wednesday, 12/13/2023
Davidow Robert L: Statement of changes in beneficial ownership of securities
3
Tuesday, 11/28/2023
Davidow Robert L: Initial statement of beneficial ownership of securities
SC 13G
Tuesday, 11/28/2023
Davidow Robert L: Major Shareholders
SC 13D/A
Monday, 9/18/2023
Fortress Biotech, Inc.: Major Shareholders
4
Tuesday, 9/12/2023
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/12/2023
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Oltmans Curtis Gale: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
KRANZLER JAY D: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Charles Faith L.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/5/2023
Jin David: Statement of changes in beneficial ownership of securities
4
Monday, 7/3/2023
MacLean Alexandra: Statement of changes in beneficial ownership of securities
4
Tuesday, 4/4/2023
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
CVI Investments, Inc.: Major Shareholders
SC 13D/A
Friday, 1/6/2023
Fortress Biotech, Inc.: Major Shareholders
SC 13G
Wednesday, 1/4/2023
SABBY MANAGEMENT, LLC: Major Shareholders
4
Wednesday, 1/4/2023
Fortress Biotech, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 12/14/2022
Nantahala Capital Management, LLC: Major Shareholders
SC 13D/A
Wednesday, 10/19/2022
InvaGen Pharmaceuticals, Inc.: Major Shareholders
SC 13G
Monday, 10/17/2022
CVI Investments, Inc.: Major Shareholders
SC 13G
Monday, 10/17/2022
INTRACOASTAL CAPITAL, LLC: Major Shareholders
4
Thursday, 10/13/2022
InvaGen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 8/3/2022
MacLean Alexandra: Initial statement of beneficial ownership of securities
SC 13D/A
Thursday, 7/28/2022
InvaGen Pharmaceuticals, Inc.: Major Shareholders
3
Wednesday, 5/25/2022
Jin David: Initial statement of beneficial ownership of securities
3
Tuesday, 5/17/2022
Charles Faith L.: Initial statement of beneficial ownership of securities
SC 13G
Monday, 2/14/2022
Nantahala Capital Management, LLC: Major Shareholders
SC 13G/A
Wednesday, 2/9/2022
VANGUARD GROUP INC: Major Shareholders
SC 13G/A
Wednesday, 2/9/2022
VANGUARD INDEX FUNDS: Major Shareholders
4
Tuesday, 12/21/2021
Oltmans Curtis Gale: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/21/2021
Herskowitz Neil: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/21/2021
Oltmans Curtis Gale: Initial statement of beneficial ownership of securities
4
Tuesday, 12/21/2021
KRANZLER JAY D: Statement of changes in beneficial ownership of securities
4
Monday, 12/20/2021
Lu Lucy: Statement of changes in beneficial ownership of securities
4
Monday, 12/20/2021
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Wednesday, 9/15/2021
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Friday, 5/7/2021
Herskowitz Neil: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/12/2021
Opaleye Management Inc.: Major Shareholders
SC 13G
Wednesday, 2/10/2021
VANGUARD GROUP INC: Major Shareholders
SC 13G
Monday, 2/8/2021
VANGUARD INDEX FUNDS: Major Shareholders
4
Friday, 8/21/2020
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
KRANZLER JAY D: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/16/2020
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/10/2020
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Monday, 3/2/2020
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/25/2020
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/25/2020
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
SC 13G/A
Friday, 2/14/2020
Opaleye Management Inc.: Major Shareholders
4
Thursday, 2/13/2020
Lu Lucy: Statement of changes in beneficial ownership of securities
4
Thursday, 2/13/2020
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
3
Tuesday, 12/31/2019
InvaGen Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 9/16/2019
Ingram Elizabeth Garrett: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/28/2019
KRANZLER JAY D: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/28/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 8/12/2019
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
3
Thursday, 8/1/2019
Ingram Elizabeth Garrett: Initial statement of beneficial ownership of securities
4
Wednesday, 6/19/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/5/2019
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/5/2019
Lu Lucy: Statement of changes in beneficial ownership of securities
3
Tuesday, 4/30/2019
Moore Thomas Gregory: Initial statement of beneficial ownership of securities
SC 13D/A
Friday, 4/19/2019
Fortress Biotech, Inc.: Major Shareholders
4
Monday, 4/15/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Friday, 3/29/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 2/25/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
3
Friday, 2/15/2019
Gogtay Jaideep Ashok: Initial statement of beneficial ownership of securities
3
Friday, 2/15/2019
Saxena Nishant: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 2/11/2019
InvaGen Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 2/6/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Friday, 2/1/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/30/2019
Herskowitz Neil: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 1/22/2019
Opaleye Management Inc.: Major Shareholders
4
Wednesday, 12/12/2018
Paley Jeffrey: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 11/23/2018
InvaGen Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 8/8/2018
WEISS MICHAEL S: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Paley Jeffrey: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
KRANZLER JAY D: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Reines Scott: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
SAMAD AKHTAR: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Lu Lucy: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/8/2018
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Thursday, 6/28/2018
Vazzano Joseph Walter: Statement of changes in beneficial ownership of securities
4
Friday, 6/15/2018
Lu Lucy: Statement of changes in beneficial ownership of securities
4/A
Tuesday, 6/12/2018
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Monday, 6/11/2018
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Wednesday, 4/25/2018
Herskowitz Neil: Statement of changes in beneficial ownership of securities
SC 13D
Thursday, 10/19/2017
Fortress Biotech, Inc.: Major Shareholders
4
Wednesday, 10/18/2017
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2017
ROSENWALD LINDSAY A MD: Statement of changes in beneficial ownership of securities
4
Tuesday, 10/10/2017
Herskowitz Neil: Statement of changes in beneficial ownership of securities
4
Monday, 10/2/2017
Lu Lucy: Statement of changes in beneficial ownership of securities
3
Monday, 9/11/2017
KRANZLER JAY D: Initial statement of beneficial ownership of securities
3
Wednesday, 9/6/2017
Reines Scott: Initial statement of beneficial ownership of securities
3
Wednesday, 8/23/2017
Fortress Biotech, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 8/22/2017
Vazzano Joseph Walter: Initial statement of beneficial ownership of securities
Prospectus (37)
424B3
Friday, 2/2/2024
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Wednesday, 1/24/2024
Registration statement for specified transactions by certain issuers
424B4
Thursday, 11/2/2023
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Tuesday, 10/24/2023
General form of registration statement for all companies including face-amount certificate companies
FWP
Thursday, 10/5/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
FWP
Wednesday, 10/4/2023
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Friday, 9/29/2023
General form of registration statement for all companies including face-amount certificate companies
S-1
Monday, 9/18/2023
General form of registration statement for all companies including face-amount certificate companies
424B3
Wednesday, 6/28/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-3
Friday, 6/16/2023
Registration statement for specified transactions by certain issuers
424B3
Thursday, 5/4/2023
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Tuesday, 4/11/2023
General form of registration statement for all companies including face-amount certificate companies
S-8
Friday, 2/10/2023
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Tuesday, 1/31/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B4
Tuesday, 10/11/2022
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Thursday, 10/6/2022
General form of registration statement for all companies including face-amount certificate companies
FWP
Thursday, 10/6/2022
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1/A
Wednesday, 10/5/2022
General form of registration statement for all companies including face-amount certificate companies
S-1
Wednesday, 8/31/2022
General form of registration statement for all companies including face-amount certificate companies
S-8
Friday, 12/17/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 12/13/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 12/10/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Tuesday, 12/7/2021
Registration statement for specified transactions by certain issuers
424B5
Wednesday, 11/10/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 11/9/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-3
Tuesday, 9/28/2021
Registration statement for specified transactions by certain issuers
S-3/A
Wednesday, 5/2/2018
Registration statement for specified transactions by certain issuers
S-3
Friday, 4/13/2018
Registration statement for specified transactions by certain issuers
S-8
Tuesday, 8/15/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B2
Wednesday, 6/28/2017
Prospectus filed pursuant to Rule 424(b)(2)
S-1MEF
Monday, 6/26/2017
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form S-1
S-1/A
Friday, 6/23/2017
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 6/23/2017
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Monday, 5/22/2017
General form of registration statement for all companies including face-amount certificate companies
S-1
Friday, 4/28/2017
General form of registration statement for all companies including face-amount certificate companies
DRS
Tuesday, 3/28/2017
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
RW
Friday, 2/26/2016
Registration Withdrawal Request
Proxies (21)
DEF 14C
Monday, 1/29/2024
Definitive information statements
PRE 14C
Wednesday, 1/17/2024
Preliminary information statement not related to a contested matter or merger/acquisition
DEFA14A
Friday, 4/28/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 4/28/2023
Definitive proxy statements
DEFA14A
Tuesday, 1/17/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFA14A
Wednesday, 1/4/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Friday, 11/18/2022
Definitive proxy statements
DEFA14A
Friday, 11/18/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Tuesday, 11/8/2022
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14C
Monday, 8/22/2022
Definitive information statements
PRE 14C
Wednesday, 8/10/2022
Preliminary information statement not related to a contested matter or merger/acquisition
DEF 14A
Tuesday, 11/23/2021
Definitive proxy statements
DEFA14A
Friday, 5/29/2020
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 4/29/2020
Definitive proxy statements
DEF 14A
Tuesday, 4/30/2019
Definitive proxy statements
DEFA14A
Friday, 1/25/2019
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEFM14A
Friday, 12/21/2018
Definitive proxy statement relating to a merger, acquisition, or disposition
PREM14A
Tuesday, 12/11/2018
Preliminary proxy statement relating to a merger, acquisition, or disposition
DEF 14A
Monday, 4/30/2018
Definitive proxy statements
DEFA14A
Monday, 4/30/2018
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Friday, 4/20/2018
Preliminary proxy statement not related to a contested matter or merger/acquisition